Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://lillinytg724045.dbblog.net/9393679/setmelanotide-a-promising-new-treatment-for-obesity